Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
In all patients, metformin 1500 mg daily for three months.
Treatment - Drugs
In all patients, metformin 1500 mg daily for three months
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with PCOS who meet the Rotterdam criteria; with top 10 score in Anxiety Inventory and top 14 score in the Beck Depression Inventory. Exclusion criteria: patient's consent to continue the study; patients who have been treated PCOS over recent 3 months; patients treated with anxiety disorders and depression; patients with diabetes; Patients with Cushing disease; hyperprolactinemia; congenital adrenal hyperplasia; Patients with serious illnesses and life threatening disease (including cancer, cirrhosis, renal failure; severe heart failure class 3 and 4 serious lung disease); pregnancy and lactation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety and depression scores. Timepoint: Baseline and three months after treatment with metformin. Method of measurement: Based on questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin resistance. Timepoint: Baseline and three months after treatment with metformin. Method of measurement: Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Niafar
Tabriz University of Medical Sciences
Outcome results
None listed